On the Pulse of
Precision
Cancer

Treatment

Skin Therapy

Delivered under local anaesthesia as a day case procedure, ePORE® therapy can be used in combination with chemotherapy for the local control of a wide range of skin cancers.

Gastrointestinal Therapy

ePORE® therapy is a precision cancer treatment addressing critical unmet challenges and symptom relief for gastrointestinal cancers.

How It Works

Our mission is for ePORE® therapy to be made available as a valuable tool for clinicians in the management of gastrointestinal and cutaneous solid tumours. We believe our technology offers tremendous potential to reduce side effects for patients while engaging a robust immune response against their cancer. - Dr Declan Soden, PhD & CEO

Addressing critical unmet challenges in global skin and gastrointestinal cancer treatment.

GI cancers account for 26% of the global cancer incidence and 35% of all cancer related deaths in 2018.
M. Arnold, "Global Burden of 5 Major Types of Gastrointestinal Cancer", Gastroenterology, no. https://doi.org/10.1053/j.gastro.2020.02.068, 2020.
By 2040, the global number of new cases of GI cancers are predicted to increase by 58% to 7.5 million.
M. Arnold, “Global Burden of 5 Major Types Of Gastrointestinal Cancer,” Gastroenterology, no. https:// doi.org/10.1053/j.gastro.2020.02.068, 2020
By 2040, global numbers of deaths from GI cancers are predicted to increase by 73% to 5.6 million.
M. Arnold, “Global Burden of 5 Major Types Of Gastrointestinal Cancer,” Gastroenterology, no. https:// doi.org/10.1053/j.gastro.2020.02.068, 2020.
In the UK, operating theater running costs are a median of £16 per minute. ePORE® therapy can be performed as a day case procedure in < 1 hour.
Volpin A, Khan O, Haddad F. Theater Cost Is £16/Minute So What Are You Doing Just Standing There?. J Arthroplasty. 2016;31(1):22-26. doi:10.1016/j.arth.2015.08.008

Targeted Therapy. Big Results.

Improved Patient Experience

  1. Precision-based technology, so only targets tumour tissue, thereby preserving healthy tissue
  2. Minimal side effects
  3. Reduces/stops bleeding associated with GI cancers
  4. Preserves cosmesis and function of treated area

Cost effective

  • Can be performed under local anaesthetic therefore reducing cost associated with the procedure
  • Patients are treated as a day-case procedure which reduces time spent in hospital

An alternative treatment option

  • For those who are at risk of going under general anaesthetic or suffer with comorbidities
  • Can be used in conjunction with other standard treatments (chemotherapy, surgery)
  • Repeatable treatment

Years of Experience

We bring together some of the best minds in electroporation and therapeutic development expertise.

Dr. Declan Soden
Founder & Chief Executive Officer
Colin Forde
Chief Operating Officer
Simon Ombler
Sales & Marketing Director
Seán Kinsella
Chief Technical Officer

Follow Our Progress